<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human parvovirus B19 causes the <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">fifth disease</z:e> (<z:hpo ids='HP_0010783'>erythema</z:hpo> infectiosum) in childhood </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1112157" disease_type="Disease or Syndrome" abbrv="">Intrauterine infection</z:e> by parvovirus in immunocompromised fetus can lead to the severe congenital <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report the case of 2.5-year-old girl with <z:e sem="disease" ids="C0275544" disease_type="Disease or Syndrome" abbrv="">congenital infection</z:e> with parvovirus B19 </plain></SENT>
<SENT sid="3" pm="."><plain>The girl was born as a pre-term baby with <z:hpo ids='HP_0000969'>hydrops</z:hpo>, congenital <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, and low level of immunoglobulins IgG and IgM </plain></SENT>
<SENT sid="4" pm="."><plain>She depended on the repeated blood transfusions and she did not respond to erythropoietin therapy </plain></SENT>
<SENT sid="5" pm="."><plain>The <z:e sem="disease" ids="C0085273" disease_type="Disease or Syndrome" abbrv="">parvovirus B19 infection</z:e> in bone marrow was detected by polymerase chain reaction and its therapy started with intravenous administration of immunoglobulins </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="0" ids="35143">Hemoglobin</z:chebi> reached <z:mpath ids='MPATH_458'>normal</z:mpath> level one year later, but low levels of parvovirus B19 were detectable for another 6 months </plain></SENT>
<SENT sid="7" pm="."><plain>Immunoglobulin treatment was finished when the virus could not be detected in the circulation </plain></SENT>
<SENT sid="8" pm="."><plain>However, one-month later parvovirus B19 DNA was detected again </plain></SENT>
<SENT sid="9" pm="."><plain>The two months course of immunoglobulin treatment was repeated, and the DNA analysis of blood cells for parvovirus B19 has been negative since then </plain></SENT>
<SENT sid="10" pm="."><plain>Five months after the final withdrawal of the immunoglobulin therapy the girl is in a good shape and <z:hpo ids='HP_0000001'>all</z:hpo> lab tests, except for the decreased levels of IgM, are within the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
<SENT sid="11" pm="."><plain>The PCR monitoring of the presence of parvovirus B19 DNA in blood and bone marrow cells during and after the treatment of congenital <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> caused by parvovirus B19 <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> becomes the necessity for the rational therapy </plain></SENT>
</text></document>